Literature DB >> 15810070

Hepatic resection for hepatocellular carcinoma in end-stage renal disease patients: two decades of experience at Chang Gung Memorial Hospital.

Chun-Nan Yeh1, Wei-Chen Lee, Miin-Fu Chen.   

Abstract

AIM: Hepatocellular carcinoma (HCC) is a common disease in Taiwan. The prevalence of viral hepatitis infection and the subsequent development of HCC are well known to be higher in patients with end-stage renal disease (ESRD) requiring hemodialysis (HD) or peritoneal dialysis (PD) than among the general population. However, information on hepatic resection for ESRD-HCC patients is limited.
METHODS: The clinical features of 26 ESRD-HCC patients who underwent hepatic resection from 1982 to 2001 were retrospectively reviewed. Meanwhile, the clinicopathological features and the outcome of 1 198 HCC patients without ESRD undergoing hepatic resection were used for comparison.
RESULTS: Of 1 224 surgically resected HCC patients, 26 (4.2%) were ESRD-HCC. Univariate analysis revealed more associated disease, more physical signs of anemia and postoperative complications, lower hemoglobin, platelet, alpha-fetoprotein, elevated blood urea nitrogen (BUN) and creatinine levels, smaller tumors, lower HBsAg positivity, higher HCV positivity, and longer hospital stays in the ESRD-HCC group compared with the HCC group. Furthermore, multivariate stepwise logistic regression analysis revealed that elevated BUN and creatinine levels were the only two independently significant factors in the patients in the ESRD-HCC group. Overall and disease-free survival rates were similar between the ESRD-HCC and HCC groups.
CONCLUSION: Elevated BUN and creatinine were the only two main independent factors differentiating ESRD-HCC from HCC patients. ESRD should not be a contraindication of hepatic resection in HCC patients; however, careful operative techniques and perioperative care are crucial to achieving lower morbidity and mortality. Comparable overall survival and disease-free survival can be achieved in selected ESRD-HCC patients undergoing hepatic resection when compared with conventional HCC patients.

Entities:  

Mesh:

Year:  2005        PMID: 15810070      PMCID: PMC4305773          DOI: 10.3748/wjg.v11.i14.20

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Abdominal operations in patients with cirrhosis: still a major surgical challenge.

Authors:  A Mansour; W Watson; V Shayani; J Pickleman
Journal:  Surgery       Date:  1997-10       Impact factor: 3.982

2.  Effect of hemodialysis on the concentration of the seven tumor markers carcinoembryonic antigen, alpha-fetoprotein, squamous cell carcinoma-related antigen, neuron-specific enolase, CA 125, CA 19-9 and CA 15-3 in uremic patients.

Authors:  E Odagiri; K Jibiki; M Takeda; H Sugimura; C Iwachika; Y Abe; K Kihara; Y Kihara; M Itou; T Nomura
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

3.  Combined liver and kidney transplantation.

Authors:  R Margreiter; R Kramar; C Huber; E Steiner; D Niederwieser; G Judmaier; W Vogel
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

4.  Possibility of hepatic resection in patients on maintenance hemodialysis.

Authors:  M Yamagata; T Kanematsu; T Matsumata; T Nishizaki; T Utsunomiya; K Sugimachi; S Okuda
Journal:  Hepatogastroenterology       Date:  1993-06

Review 5.  Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients.

Authors:  F Nomura; K Ohnishi; Y Tanabe
Journal:  Cancer       Date:  1989-10-15       Impact factor: 6.860

Review 6.  Hepatitis in patients with end-stage renal disease.

Authors:  C C Huang
Journal:  J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 4.029

7.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

8.  Mortality in dialysis patients: analysis of the causes of death.

Authors:  L U Mailloux; A G Bellucci; B M Wilkes; B Napolitano; R T Mossey; M Lesser; P A Bluestone
Journal:  Am J Kidney Dis       Date:  1991-09       Impact factor: 8.860

9.  Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan.

Authors:  Miin-Fu Chen; Long-Bin Jeng; Wei-Chen Lee
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.

Authors:  C C Huang; M S Wu; D Y Lin; Y F Liaw
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

View more
  11 in total

1.  Efficacy of a liver resection for hepatocellular carcinoma in patients with chronic renal failure.

Authors:  Takashi Orii; Tetsuro Takayama; Izumi Haga; Tatsuya Fukumori; Noritoshi Amada
Journal:  Surg Today       Date:  2008-03-27       Impact factor: 2.549

2.  Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction.

Authors:  Takeo Toshima; Ken Shirabe; Shohei Yoshiya; Jun Muto; Toru Ikegami; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

3.  Hepatic and pancreatic resection in patients with end-stage renal disease: a propensity analysis.

Authors:  Andrew S Barbas; Paul J Speicher; Bryan M Clary
Journal:  HPB (Oxford)       Date:  2014-06-16       Impact factor: 3.647

4.  Hepatocellular carcinoma in patients with chronic kidney disease.

Authors:  Chern-Horng Lee; Sen-Yung Hsieh; Ja-Liang Lin; Maw-Sen Liu; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

5.  Hepatic resection for hepatocellular carcinoma patients on hemodialysis for uremia: a nationwide cohort study.

Authors:  Chun-Chieh Yeh; Jaw-Town Lin; Long-Bin Jeng; Iakovidis Charalampos; Tzu-Ting Chen; Teng-Yu Lee; Ming-Shiang Wu; Ken N Kuo; Yi-Ya Liu; Chun-Ying Wu
Journal:  World J Surg       Date:  2013-10       Impact factor: 3.352

6.  Association of dialysis with adverse postoperative outcomes in colorectal cancer-an analysis of ACS-NSQIP.

Authors:  Wan-Hsiang Hu; Luis Carlos Cajas-Monson; Samuel Eisenstein; Lisa Parry; Sonia Ramamoorthy
Journal:  Int J Colorectal Dis       Date:  2015-08-05       Impact factor: 2.571

7.  Hepatocellular carcinoma in hemodialysis patients.

Authors:  Chern-Horng Lee; Sen-Yung Hsieh; Chih-Chun Chang; I-Kuan Wang; Wen-Hung Huang; Cheng-Hao Weng; Ching-Wei Hsu; Tzung-Hai Yen
Journal:  Oncotarget       Date:  2017-04-16

8.  Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction.

Authors:  Chikara Shirata; Kiyoshi Hasegawa; Takashi Kokudo; Suguru Yamashita; Satoshi Yamamoto; Junichi Arita; Nobuhisa Akamatsu; Junichi Kaneko; Yoshihiro Sakamoto; Norihiro Kokudo
Journal:  World J Surg       Date:  2018-12       Impact factor: 3.352

9.  Preoperative risk score predicting 90-day mortality after liver resection in a population-based study.

Authors:  Chun-Ming Chang; Wen-Yao Yin; Yu-Chieh Su; Chang-Kao Wei; Cheng-Hung Lee; Shiun-Yang Juang; Yi-Ting Chen; Jin-Cherng Chen; Ching-Chih Lee
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

Review 10.  Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges.

Authors:  Hsuan Yeh; Chung-Cheng Chiang; Tzung-Hai Yen
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.